Multivalent Small-Molecule Pan-RAS Inhibitors

Welsch, M; Kaplan, A.; Chambers, J.; Stokes, M.; Bos, P.; Zask, A.; Zhang, Y.; Sanchez-Martin, M.; Badgley, M.; Huang, C.; Tran, T.; Akkiraju, H.; Brown, L.; Nandakumar, R.; Cremers, S.; Yang, W.; Tong, L.; Olive, K.; Ferrando, A.; Stockwell, B.

doi:10.1016/j.cell.2017.02.006

Multivalent Small-Molecule Pan-RAS Inhibitors

Journal Article · 01 January 2022 · Cell

DOI:https://doi.org/10.1016/j.cell.2017.02.006· OSTI ID:1783961

Welsch, M; Kaplan, A.; Chambers, J.; Stokes, M.; Bos, P.; Zask, A.; Zhang, Y.; Sanchez-Martin, M.; Badgley, M.; Huang, C.; Tran, T.; Akkiraju, H.; Brown, L.; Nandakumar, R.; Cremers, S.; Yang, W.; Tong, L.; Olive, K.; Ferrando, A.; Stockwell, B.

Research Organization:: Brookhaven National Lab. (BNL), Upton, NY (United States)

Sponsoring Organization:: ~OTHER

DOE Contract Number:: SC0012704

OSTI ID:: 1783961

Report Number(s):: BNL-221492-2021-JACI

Journal Information:: Cell, Vol. 168, Issue 5

Country of Publication:: United States

Language:: English

References (54)

PHENIX : building new software for automated crystallographic structure determination Adams, Paul D.; Grosse-Kunstleve, Ralf W.; Hung, Li-Wei Acta Crystallographica Section D Biological Crystallography, Vol. 58, Issue 11 https://doi.org/10.1107/S0907444902016657	journal	October 2002
Small-molecule inhibitors of protein–protein interactions: progressing towards the dream Arkin, Michelle R.; Wells, James A. Nature Reviews Drug Discovery, Vol. 3, Issue 4 https://doi.org/10.1038/nrd1343	journal	April 2004
Small-Molecule Inhibitors of Protein-Protein Interactions: Progressing toward the Reality Arkin, Michelle R.; Tang, Yinyan; Wells, James A. Chemistry & Biology, Vol. 21, Issue 9 https://doi.org/10.1016/j.chembiol.2014.09.001	journal	September 2014
Both p16Ink4a and the p19Arf-p53 pathway constrain progression of pancreatic adenocarcinoma in the mouse Bardeesy, N.; Aguirre, A. J.; Chu, G. C. Proceedings of the National Academy of Sciences, Vol. 103, Issue 15 https://doi.org/10.1073/pnas.0601273103	journal	April 2006
Quantitative structure-activity analysis correlating Ras/Raf interaction in vitro to Raf activation in vivo Block, Christoph; Janknecht, Ralf; Herrmann, Christian Nature Structural Biology, Vol. 3, Issue 3 https://doi.org/10.1038/nsb0396-244	journal	March 1996
Approach for targeting Ras with small molecules that activate SOS-mediated nucleotide exchange Burns, Michael C.; Sun, Qi; Daniels, R. Nathan Proceedings of the National Academy of Sciences, Vol. 111, Issue 9 https://doi.org/10.1073/pnas.1315798111	journal	February 2014
Improvements in survival and clinical benefit with gemcitabine as first-line therapy for patients with advanced pancreas cancer: a randomized trial. Burris, H. A.; Moore, M. J.; Andersen, J. Journal of Clinical Oncology, Vol. 15, Issue 6 https://doi.org/10.1200/JCO.1997.15.6.2403	journal	June 1997
Leukemia-associated NOTCH1 alleles are weak tumor initiators but accelerate K-ras–initiated leukemia Chiang, Mark Y.; Xu, Lanwei; Shestova, Olga Journal of Clinical Investigation, Vol. 118, Issue 9 https://doi.org/10.1172/JCI35090	journal	September 2008
Methods to measure the intracellular concentration of unlabeled compounds within cultured cells using liquid chromatography/tandem mass spectrometry Colletti, Lynn M.; Liu, Yaya; Koev, Gennadiy Analytical Biochemistry, Vol. 383, Issue 2 https://doi.org/10.1016/j.ab.2008.08.012	journal	December 2008
Drugging the undruggable RAS: Mission Possible? Cox, Adrienne D.; Fesik, Stephen W.; Kimmelman, Alec C. Nature Reviews Drug Discovery, Vol. 13, Issue 11 https://doi.org/10.1038/nrd4389	journal	October 2014
Identification of genotype-selective antitumor agents using synthetic lethal chemical screening in engineered human tumor cells Dolma, Sonam; Lessnick, Stephen L.; Hahn, William C. Cancer Cell, Vol. 3, Issue 3 https://doi.org/10.1016/S1535-6108(03)00050-3	journal	March 2003
Targeting RAS signalling pathways in cancer therapy Downward, Julian Nature Reviews Cancer, Vol. 3, Issue 1 https://doi.org/10.1038/nrc969	journal	January 2003
Therapeutic Strategies for Targeting Ras Proteins Gysin, S.; Salt, M.; Young, A. Genes & Cancer, Vol. 2, Issue 3 https://doi.org/10.1177/1947601911412376	journal	March 2011
The structural basis for the transition from Ras-GTP to Ras-GDP Hall, B. E.; Bar-Sagi, D.; Nassar, N. Proceedings of the National Academy of Sciences, Vol. 99, Issue 19 https://doi.org/10.1073/pnas.192453199	journal	September 2002
Metal complexes as “protein surface mimetics” Hewitt, Sarah H.; Wilson, Andrew J. Chemical Communications, Vol. 52, Issue 63 https://doi.org/10.1039/C6CC03457H	journal	January 2016
The druggable genome Hopkins, Andrew L.; Groom, Colin R. Nature Reviews Drug Discovery, Vol. 1, Issue 9 https://doi.org/10.1038/nrd892	journal	September 2002
Three-dimensional structure of the Ras-interacting domain of RalGDS Huang, Lan; Weng, Xiangwei; Hofer, Franz Natural Structural Biology, Vol. 4, Issue 8 https://doi.org/10.1038/nsb0897-609	journal	August 1997
Structural basis for the interaction of Ras with RaIGDS Huang, Lan; Hofer, Franz; Martin, G. Steven Nature Structural Biology, Vol. 5, Issue 6 https://doi.org/10.1038/nsb0698-422	journal	June 1998
K-ras is an essential gene in the mouse with partial functional overlap with N-ras Johnson, L.; Greenbaum, D.; Cichowski, K. Genes & Development, Vol. 11, Issue 19 https://doi.org/10.1101/gad.11.19.2468	journal	October 1997
The Concept of Synthetic Lethality in the Context of Anticancer Therapy Kaelin, William G. Nature Reviews Cancer, Vol. 5, Issue 9 https://doi.org/10.1038/nrc1691	journal	August 2005
Ras oncogenes: split personalities Karnoub, Antoine E.; Weinberg, Robert A. Nature Reviews Molecular Cell Biology, Vol. 9, Issue 7 https://doi.org/10.1038/nrm2438	journal	July 2008
RAS oncogenes: the first 30 years Malumbres, Marcos; Barbacid, Mariano Nature Reviews Cancer, Vol. 3, Issue 6 https://doi.org/10.1038/nrc1097	journal	June 2003
Small-molecule ligands bind to a distinct pocket in Ras and inhibit SOS-mediated nucleotide exchange activity Maurer, T.; Garrenton, L. S.; Oh, A. Proceedings of the National Academy of Sciences, Vol. 109, Issue 14 https://doi.org/10.1073/pnas.1116510109	journal	March 2012
Cancer therapy based on oncogene addiction: Cancer Therapy Based on Oncogene Addiction McCormick, Frank Journal of Surgical Oncology, Vol. 103, Issue 6 https://doi.org/10.1002/jso.21749	journal	April 2011
Phaser crystallographic software McCoy, Airlie J.; Grosse-Kunstleve, Ralf W.; Adams, Paul D. Journal of Applied Crystallography, Vol. 40, Issue 4 https://doi.org/10.1107/S0021889807021206	journal	July 2007
Refinement of Macromolecular Structures by the Maximum-Likelihood Method Murshudov, G. N.; Vagin, A. A.; Dodson, E. J. Acta Crystallographica Section D Biological Crystallography, Vol. 53, Issue 3 https://doi.org/10.1107/S0907444996012255	journal	May 1997
Pancreatic cancer: why is it so hard to treat? Oberstein, Paul E.; Olive, Kenneth P. Therapeutic Advances in Gastroenterology, Vol. 6, Issue 4 https://doi.org/10.1177/1756283X13478680	journal	March 2013
Direct small-molecule inhibitors of KRAS: from structural insights to mechanism-based design Ostrem, Jonathan M. L.; Shokat, Kevan M. Nature Reviews Drug Discovery, Vol. 15, Issue 11 https://doi.org/10.1038/nrd.2016.139	journal	July 2016
K-Ras(G12C) inhibitors allosterically control GTP affinity and effector interactions Ostrem, Jonathan M.; Peters, Ulf; Sos, Martin L. Nature, Vol. 503, Issue 7477 https://doi.org/10.1038/nature12796	journal	November 2013
[20] Processing of X-ray diffraction data collected in oscillation mode Otwinowski, Zbyszek; Minor, Wladek Macromolecular Crystallography Part A, 307-326 https://doi.org/10.1016/S0076-6879(97)76066-X	book	January 1997
Crystal Structure and Functional Analysis of Ras Binding to Its Effector Phosphoinositide 3-Kinase γ Pacold, Michael E.; Suire, Sabine; Perisic, Olga Cell, Vol. 103, Issue 6 https://doi.org/10.1016/S0092-8674(00)00196-3	journal	December 2000
Direct Reversal of Glucocorticoid Resistance by AKT Inhibition in Acute Lymphoblastic Leukemia Piovan, Erich; Yu, Jiyang; Tosello, Valeria Cancer Cell, Vol. 24, Issue 6 https://doi.org/10.1016/j.ccr.2013.10.022	journal	December 2013
Ras trafficking, localization and compartmentalized signalling Prior, Ian A.; Hancock, John F. Seminars in Cell & Developmental Biology, Vol. 23, Issue 2 https://doi.org/10.1016/j.semcdb.2011.09.002	journal	April 2012
A Comprehensive Survey of Ras Mutations in Cancer Prior, I. A.; Lewis, P. D.; Mattos, C. Cancer Research, Vol. 72, Issue 10 https://doi.org/10.1158/0008-5472.CAN-11-2612	journal	May 2012
Acquisition of Mouse Tumor Biopsies through Abdominal Laparotomy Sastra, Stephen A.; Olive, Kenneth P. Cold Spring Harbor Protocols, Vol. 2014, Issue 1 https://doi.org/10.1101/pdb.prot077834	journal	December 2013
The Ras-RasGAP Complex: Structural Basis for GTPase Activation and Its Loss in Oncogenic Ras Mutants Scheffzek, K. Science, Vol. 277, Issue 5324 https://doi.org/10.1126/science.277.5324.333	journal	July 1997
Ras, PI(3)K and mTOR signalling controls tumour cell growth Shaw, Reuben J.; Cantley, Lewis C. Nature, Vol. 441, Issue 7092 https://doi.org/10.1038/nature04869	journal	May 2006
In silico discovery of small-molecule Ras inhibitors that display antitumor activity by blocking the Ras-effector interaction Shima, F.; Yoshikawa, Y.; Ye, M. Proceedings of the National Academy of Sciences, Vol. 110, Issue 20 https://doi.org/10.1073/pnas.1217730110	journal	April 2013
Small-molecule modulation of Ras signaling Spiegel, Jochen; Cromm, Philipp M.; Zimmermann, Gunther Nature Chemical Biology, Vol. 10, Issue 8 https://doi.org/10.1038/nchembio.1560	journal	June 2014
Dragging Ras Back in the Ring Stephen, Andrew G.; Esposito, Dominic; Bagni, Rachel K. Cancer Cell, Vol. 25, Issue 3 https://doi.org/10.1016/j.ccr.2014.02.017	journal	March 2014
Discovery of Small Molecules that Bind to K-Ras and Inhibit Sos-Mediated Activation Sun, Qi; Burke, Jason P.; Phan, Jason Angewandte Chemie International Edition, Vol. 51, Issue 25 https://doi.org/10.1002/anie.201201358	journal	May 2012
A method for the second-site screening of K-Ras in the presence of a covalently attached first-site ligand Sun, Qi; Phan, Jason; Friberg, Anders R. Journal of Biomolecular NMR, Vol. 60, Issue 1 https://doi.org/10.1007/s10858-014-9849-8	journal	August 2014
Interfering with RAS–effector protein interactions prevent RAS-dependent tumour initiation and causes stop–start control of cancer growth Tanaka, T.; Rabbitts, T. H. Oncogene, Vol. 29, Issue 45 https://doi.org/10.1038/onc.2010.346	journal	September 2010
Visualization of Ras-PI3K interaction in the endosome using BiFC Tsutsumi, Kaori; Fujioka, Yoichiro; Tsuda, Masumi Cellular Signalling, Vol. 21, Issue 11 https://doi.org/10.1016/j.cellsig.2009.07.004	journal	November 2009
Using cells devoid of RAS proteins as tools for drug discovery Urosevic, Jelena; Sum, Eleanor Y. M.; Moneo, Victoria Molecular Carcinogenesis, Vol. 48, Issue 11 https://doi.org/10.1002/mc.20555	journal	November 2009
Chemical Biology Tools for Regulating RAS Signaling Complexity in Space and Time van Hattum, Hilde; Waldmann, Herbert Chemistry & Biology, Vol. 21, Issue 9 https://doi.org/10.1016/j.chembiol.2014.08.001	journal	September 2014
In Vivo Activation of the p53 Pathway by Small-Molecule Antagonists of MDM2 Vassilev, L. T. Science, Vol. 303, Issue 5659 https://doi.org/10.1126/science.1092472	journal	February 2004
Ras superfamily GEFs and GAPs: validated and tractable targets for cancer therapy? Vigil, Dominico; Cherfils, Jacqueline; Rossman, Kent L. Nature Reviews Cancer, Vol. 10, Issue 12 https://doi.org/10.1038/nrc2960	journal	November 2010
1H, 13C and 15N resonance assignment for the human K-Ras at physiological pH Vo, Uybach; Embrey, Kevin J.; Breeze, Alexander L. Biomolecular NMR Assignments, Vol. 7, Issue 2 https://doi.org/10.1007/s12104-012-9413-y	journal	August 2012
Targeting Ras and Rho GTPases as opportunities for cancer therapeutics Walker, Katharine; Olson, Michael F. Current Opinion in Genetics & Development, Vol. 15, Issue 1 https://doi.org/10.1016/j.gde.2004.11.001	journal	February 2005
Ras inhibition via direct Ras binding—is there a path forward? Wang, Weiru; Fang, Guowei; Rudolph, Joachim Bioorganic & Medicinal Chemistry Letters, Vol. 22, Issue 18 https://doi.org/10.1016/j.bmcl.2012.07.082	journal	September 2012
Targeting oncogenic Ras signaling in hematologic malignancies Ward, Ashley F.; Braun, Benjamin S.; Shannon, Kevin M. Blood, Vol. 120, Issue 17 https://doi.org/10.1182/blood-2012-05-378596	journal	October 2012
Development of small-molecule probes that selectively kill cells induced to express mutant RAS Weïwer, Michel; Bittker, Joshua A.; Lewis, Timothy A. Bioorganic & Medicinal Chemistry Letters, Vol. 22, Issue 4 https://doi.org/10.1016/j.bmcl.2011.09.047	journal	February 2012
Synthetic Lethal Screening Identifies Compounds Activating Iron-Dependent, Nonapoptotic Cell Death in Oncogenic-RAS-Harboring Cancer Cells Yang, Wan Seok; Stockwell, Brent R. Chemistry & Biology, Vol. 15, Issue 3 https://doi.org/10.1016/j.chembiol.2008.02.010	journal	March 2008

Similar Records

Discovery of 1-(3,3-Dimethylbutyl)-3-(2-fluoro-4-methyl-5-(7-methyl-2-(methylamino)pyrido[2,3-d]pyrimidin-6-yl)phenyl)urea (LY3009120) as a Pan-RAF Inhibitor with Minimal Paradoxical Activation and Activity against BRAF or RAS Mutant Tumor Cells

Journal Article · 2015 · Journal of Medicinal Chemistry · OSTI ID:1240168

Henry, James R.; Kaufman, Michael D.; Peng, Sheng-Bin; +30 more

Targeting allostery in the Dynein motor domain with small molecule inhibitors

Journal Article · 2023 · Cell Chemical Biology · OSTI ID:1827820

Santarossa, C; Mickolajczyk, K.; Steinman, J.; +8 more

Structural Insights into the Induced-fit Inhibition of Fascin by a Small-Molecule Inhibitor

Journal Article · 2018 · Journal of Molecular Biology · OSTI ID:1466640

Huang, Jianyun; Dey, Raja; Wang, Yufeng; +3 more

Related Subjects

99 GENERAL AND MISCELLANEOUS

Multivalent Small-Molecule Pan-RAS Inhibitors

Citation Formats

References (54)

Similar Records

Related Subjects